Valuation : Anupam Rasayan India Ltd

Market Cap 139B 1.45B 1.25B 1.19B 1.07B 2.02B 2.03B 14.08B 5.41B 70.63B 5.46B 5.34B 223B P/E 2026
81.6x
P/E 2027 * 50.2x
Enterprise Value 144B 1.51B 1.3B 1.23B 1.11B 2.09B 2.1B 14.6B 5.62B 73.25B 5.66B 5.54B 231B EV / Sales 2026
6.55x
EV / Sales 2027 * 4.54x
Free-Float
16.06%
Yield 2026
0.12%
Yield 2027 * 0.17%
09-09 Tanfac Industries Limited announced that it has received INR 994.098627 million in funding from Anupam Rasayan India Ltd, Alrox Enterprises Private Limited and other investor. CI
09-08 Anupam Rasayan India Ltd Appoints Hetvi Vyas, as Deputy Chief Financial Officer and Key Managerial Personnel CI
09-06 Anupam Rasayan India Limited Secures Chemical Supply Contract With Major Speciality Metal Manufacturer CI
08-15 Anupam Rasayan India Ltd, Q1 2027 Earnings Call, Aug 14, 2026
08-15 Anupam Rasayan India Ltd Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
08-14 Anupam Rasayan India Limited Announces Appointment of Ravi Desai to Chief Operating Officer, Effective August 14, 2026 CI
07-17 Anupam Rasayan India Ltd acquired Mates Visa Consultancy Private Limited for INR 0.01 million. CI
07-15 Anupam Rasayan India Limited Signs Letter Of Intent With BASQUEVOLT, S.A. For Potential Long-Term Supply Of Specialty Chemical Product Worth USD 300 Million CI
07-06 Tanfac Industries Limited announced that it expects to receive INR 1.734873 billion in funding from Anupam Rasayan India Ltd, Alrox Enterprises Private Limited and other investor. CI
06-11 Anupam Rasayan India Limited Commercialises ETFA Using Flow Chemistry CI
06-04 Crisil Places Anupam Rasayan Ratings on Watch Developing After Bliss GVS Acquisition Announcement MT
05-25 Anupam Rasayan India Ltd, Q4 2026 Earnings Call, May 25, 2026
05-23 Anupam Rasayan India Ltd Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
1 day-0.95%
1 week-1.68%
Current month-3.44%
1 month+0.25%
3 months-4.16%
6 months-5.77%
Current year-7.54%
1 week 1,205
Extreme 1205
1,266.3
1 month 1,192.3
Extreme 1192.3
1,273.9
Current year 1,162.3
Extreme 1162.3
1,415
1 year 1,045.2
Extreme 1045.2
1,415
3 years 601
Extreme 601
1,415
5 years 546.75
Extreme 546.75
1,415
10 years 474
Extreme 474
1,415
Manager TitleAgeSince
Chief Executive Officer - 11/09/2023
Director of Finance/CFO 36 15/03/2022
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 50 23/04/2013
Director/Board Member 52 01/01/1992
Chairman 77 31/08/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.95%-1.68%+11.16%+23.88% 1.47B
+1.96%-0.86%+0.73%+50.60% 76.14B
-0.16%-3.62%-0.24%-23.90% 36.64B
+0.16%-2.65%-7.51%+9.75% 35.94B
-0.22%-2.98%-11.72%+10.32% 25.09B
+0.13%+0.89%+31.79%+22.56% 22.92B
-2.86%-7.85%+65.29%+18.19% 20.71B
-0.43%-3.69%-45.84%-44.00% 17.19B
-2.85%-6.26%+57.73%-36.46% 14.41B
-0.86%-3.54%+7.44%-4.47% 13.99B
Average -0.60%-3.49%+10.88%+2.65% 26.45B
Weighted average by Cap. +0.12%-3.30%+6.53%+11.99%

Financials

2026 2027 *
Net sales 22.24B 233M 201M 190M 172M 323M 325M 2.26B 867M 11.31B 874M 855M 35.75B 34.12B 357M 308M 291M 264M 495M 498M 3.46B 1.33B 17.36B 1.34B 1.31B 54.85B
Net income 1.59B 16.63M 14.33M 13.57M 12.3M 23.07M 23.19M 161M 61.97M 808M 62.47M 61.09M 2.55B 2.74B 28.69M 24.72M 23.41M 21.22M 39.8M 40M 278M 107M 1.39B 108M 105M 4.41B
Net Debt 5.16B 54M 46.53M 44.06M 39.93M 74.91M 75.29M 523M 201M 2.62B 203M 198M 8.29B 16.14B 169M 146M 138M 125M 234M 235M 1.64B 629M 8.21B 634M 620M 25.94B
Logo Anupam Rasayan India Ltd
Anupam Rasayan India Ltd. is an India-based company, which is engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals. The Company's segments include Life Science related Specialty Chemicals and Other Specialty Chemicals. The Life Science related Specialty Chemicals segment includes agrochemicals (including crop protection), personal care, and pharmaceuticals businesses. Its agrochemicals business includes manufacturing agro intermediates and active ingredients, such as insecticides, fungicides, herbicides and plant growth regulators. Its personal care business manufactures antibacterial and ultraviolet protection intermediates. Its pharmaceuticals business develops intermediates and key starting materials for active pharmaceutical ingredients used in therapeutic segments, including cardiovascular and antidiabetic. The Other Specialty Chemicals segment includes specialty pigments, specialty dyes, and polymer additives. It caters to Indian and global customers.
Employees
2,606
Date Price Change Volume
11/09/26 1,219.40 -0.95% 418,693
10/09/26 ₹1,231.10 +0.12% 33,522
09/09/26 ₹1,229.60 -0.31% 204,066
08/09/26 ₹1,233.40 -0.02% 137,762
07/09/26 ₹1,233.60 -0.41% 286,021
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
1,219.40INR
Average target price
1,215.71INR
Spread / Average Target
-0.30%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ANURAS Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!